Preview

Diabetes mellitus

Advanced search

Evolution of blood glucose self-monitoring technology

https://doi.org/10.14341/DM13063

Abstract

In 1838 G. Rees, a doctor from London (Guy's Hospital), for the first time isolated excess sugar from the blood serum of a patient with diabetes mellitus. Diagnosis of diabetes mellitus gradually developed. The next step was the understanding that regular monitoring of glucose levels by the patient himself is an integral part of diabetes mellitus therapy. The starting point of the technology for self-monitoring of diabetes mellitus was the determination of the sugar content in urine using chemical reactions. The method had no great clinical significance, it only indicated a progressive disease. The first Dextrostix blood glucose test strip (Ames-Mile's laboratories) was introduced in 1964. In 1970, the first automated blood glucose analysis system, the Ames Reflectance Meter (ARM), was created. Over time, the technology has been improved, accuracy, visibility, comfort, and an individual approach to glucometry have been formed. A new chapter was the development of remote technologies and the possibility of remote monitoring. More advanced data processing is now available in tabular and graphical form, with the calculation of 7-, 14-, 30-, and 90-day average glycemic values. A promising direction is the introduction of artificial intelligence in the management of diabetes mellitus.

About the Authors

L. A. Suplotova
Tyumen State Medical University
Russian Federation

Lyudmila A. Suplotova, MD, PhD, Professor

54 Odesskaya street, 625023 Tyumen



O. O. Alieva
Tyumen State Medical University
Russian Federation

Oksana O. Alieva, PhD student

Tyumen



References

1. Resolution on diabetes mellitus from United Nations organization. Diabetes mellitus. 2007;10(1):2-3. (In Russ.). doi: https://doi.org/10.14341/2072–0351–5906

2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. 2021 [cited 05.12.2023]. Available from: https://diabetesatlas.org/

3. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775-784. doi: https://doi.org/10.1089/dia.2009.0091

4. Skeie S, Kristensen GB, Carlsen S, Sandberg S. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol. 2009;3(1):83-88. doi: https://doi.org/10.1177/193229680900300109

5. Nathan D.M., Genuth S., Lachin J., et al. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986. doi: https://doi.org/10.1056/NEJM199309303291401

6. Gubitosi-Klug RA, Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) study research group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686-693. doi: https://doi.org/10.2337/dc15-1990

7. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643-648. doi: https://doi.org/10.1046/j.1365-2125.1999. 00092.x

8. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-117. doi: https://doi.org/10.1016/0168-8227(95)01064-K

9. Laiteerapong N, Ham SA, Gao Y, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (The Diabetes & Aging Study). Diabetes Care. 2019;42(3):416-426. doi: https://doi.org/10.2337/dc17-1144

10. Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93. doi: https://doi.org/10.1080/09674845.2012.12002443

11. March CA, Libman IM, Becker DJ, Levitsky LL. From antiquity to modern times: A history of diabetes mellitus and its treatments. Horm Res Paediatr. 2022;95(6):593-607. doi: https://doi.org/10.1159/000526441

12. Selea Zivojinovic A. Blood Glucose Monitoring. In: Basics of Hypoglycemia. IntechOpen; 2022;42:416-426. doi: https://doi.org/10.5772/intechopen.105605

13. Mazzaferri EL, Skillman TG, Lanese RR, Keller MP. Use of test strips with colour meter to measure blood-glucose. Lancet. 1970;1(7642):331-333. doi: https://doi.org/10.1016/s0140-6736(70)90706-3

14. Cavell B, Svenningsen N, Thulin T, Scherstén B. Rapid detection of neonatal hypoglycaemia. Evaluation of dextrostix reflectance meter system. Arch Dis Child. 1973;48(5):398-400. doi: https://doi.org/10.1136/adc.48.5.398

15. Schersten B, Kuhl C, Hollender A, Ekman R. Blood glucose measurement with Dextrostix and new reflectance meter. Br Med J. 1974;3(5927):384-387. doi: https://doi.org/10.1136/bmj.3.5927.384

16. Walford S, Gale EA, Allison SP, Tattersall RB. Selfmonitoring of blood-glucose. Improvement of diabetic control. Lancet. 1978;1(8067):732-735. doi: https://doi.org/10.1016/s0140-6736(78)90855-3

17. Irsigler K, Bali-Taubald C. Self-monitored blood glucose: the essential biofeedback signal in the diabetic patient’s effort to achieve normoglycemia. Diabetes Care. 1980;3(1):163-170. doi: https://doi.org/10.2337/diacare.3.1.163

18. Leroux ML, Desjardins PR. Ward level evaluation of the “One Touch” glucose meter. Clin Chem. 1988;34(9):1928-1928. doi: https://doi.org/10.1093/clinchem/34.9.1928a

19. Strowig SM, Raskin P. Improved glycemic control in intensively treated type 1 diabetic patients using blood glucose meters with storage capability and computerassisted analyses. Diabetes Care. 1998;21(10):1694-1698. doi: https://doi.org/10.2337/diacare.21.10.1694

20. Clarke WL, Cox D, Gonder-Frederick LA, et al. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987;10(5):622-628. doi: https://doi.org/10.2337/diacare.10.5.622

21. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143-1148. doi: https://doi.org/10.2337/diacare.23.8.1143

22. Ross D, Heinemann L, Chantelau EA. Short-term evaluation of an electro-chemical system (ExacTech) for blood glucose monitoring. Diabetes Res Clin Pract. 1990;10(3):281-285. doi: https://doi.org/10.1016/0168-8227(90)90071-z

23. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971-980. doi: https://doi.org/10.1177/193229680900300446

24. eltaltd.ru [Internet]. Istorija kompanii. (In Russ.). Доступно по: https://eltaltd.ru/about/. Ссылка активна на 26.05.2023.

25. International Organization for Standardization. In vitro diagnostic test systems for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva: ISO; 2003.

26. State Standard R ISO 15197-2009. In vitro diagnostic test systems. Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (In Russ.).

27. Harrison B, Leazenby C, Halldorsdottir S. Accuracy of the CONTOUR® blood glucose monitoring system. J Diabetes Sci Technol. 2011;5(4):1009-1013. doi: https://doi.org/10.1177/193229681100500425

28. Il’iasov IR, Kartavenkov SA, Mishchenko BP, Smirnov VA. Mnogocentrovoe kliniko-laboratornoe issledovanie tochnosti portativnogo gljukometra «Satellit Pljus». Klin Lab Diagn. 2012;(8):23-25 (In Russ.).

29. The Diabetes Research In Children N. A Multicenter Study of the Accuracy of the One Touch® Ultra® Home Glucose Meter in Children with Type 1 Diabetes. Diabetes Technol Ther. 2003;5(6):933-941. doi: https://doi.org/10.1089/152091503322640971

30. Ito T, Kamoi K, Minagawa S, et al. Patient perceptions of different lancing sites for self-monitoring of blood glucose: a comparison of fingertip site with palm site using the OneTouch Ultra Blood Glucose Monitoring System. J Diabetes Sci Technol. 2010;4(4):906-910. doi: https://doi.org/10.1177/193229681000400420

31. Laffel LM, Hsu WC, McGill JB, et al. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial. Diabetes Technol Ther. 2007;9(3):254-264. doi: https://doi.org/10.1089/dia.2006.0021

32. Kesavadev J, Chandran GB, Basanth A, et al. Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes. Diabetes Metab Syndr Clin Res Rev. 2023;17(3):102731. doi: https://doi.org/10.1016/j.dsx.2023.102731

33. Mianowska B, Mlynarski W, Szadkowska I, Szadkowska A. Evaluation of three lancing devices: What do blood volume and lancing pain depend on? J Diabetes Sci Technol. 2021;15(5):1076-1083. doi: https://doi.org/10.1177/1932296820949930

34. Grady M, Lamps G, Shemain A, et al. Clinical evaluation of a new, lower pain, one touch lancing device for people with diabetes: virtually pain-free testing and improved comfort compared to current lancing systems. J Diabetes Sci Technol. 2021;15(1):53-59. doi: https://doi.org/10.1177/1932296819856665

35. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care (10-th edition). Diabetes Mellitus. 2021;24(S1):1-235 (In Russ.). doi: https://doi.org/10.14341/DM12802

36. Harrison B, Brown D. Accuracy of a blood glucose monitoring system that recognizes insufficient sample blood volume and allows application of more blood to the same test strip. Expert Rev Med Devices. 2020;17(1):75-82. doi: https://doi.org/10.1080/17434440.2020.1704253

37. Dianov O.A., Maltsev V.V., Murina E.S., Anfilov I.S. Accuracy assessment of the blood glucose meter «Satellite Express» for glycemic control in children with diabetes. Problems of Endocrinology. 2019;65(6):436-443. (In Russ.). doi: https://doi.org/10.14341/probl12311

38. Kurnikova IA, Ualihanova AU, Morgunov LY, et al. Evaluation of the efficiency of using glucose monitoring devices upon unsatisfactory diabetes compensation. Problems of Endocrinology. 2017;63(1):23-29. (In Russ.). doi: https://doi.org/10.14341/probl201763123-29

39. Grady M, Katz LB, Levy BL. Use of blood glucose meters featuring color range indicators improves glycemic control in patients with diabetes in comparison to blood glucose meters without color (ACCENTS Study). J Diabetes Sci Technol. 2018;12(6):1211-1219. doi: https://doi.org/10.1177/1932296818775755

40. Al Hayek A, Alwin Robert A, Al Dawish M. Clinical characteristics and glucose monitoring satisfaction associated with blood glucose meter featuring color range indicator in patients with type 2 diabetes. J Diabetes Sci Technol. 2021;15(1):188-190. doi: https://doi.org/10.1177/1932296820934883

41. Nicolucci A, Rossi MC, Cherubini V, et al. Comparative efficacy of iBGStar™ glucose meter vs. a traditional glucose meter in type 1 diabetes. J Diabetes Metab. 2014;5(6): 382. doi: https://doi.org/10.4172/2155-6156.1000382

42. Garg SK, Shah VN, Akturk HK, et al. Role of mobile technology to improve diabetes care in adults with type 1 diabetes: The remoteT1D study iBGStar® in type 1 diabetes management. Diabetes Ther. 2017;8(4):811-819. doi: https://doi.org/10.1007/s13300-017-0272-5

43. Di Bartolo P, Nicolucci A, Cherubini V, et al. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial. Acta Diabetol. 2017;54(4):393-402. doi: https://doi.org/10.1007/s00592-017-0963-4

44. Di Molfetta S, Patruno P, Cormio S, et al. A telemedicinebased approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. J Endocrinol Invest. 2022;45(9):1663-1671. doi: https://doi.org/10.1007/s40618-022-01802-w

45. Debong F, Mayer H, Kober J. Real-world assessments of mySugr mobile health app. Diabetes Technol Ther. 2019;21(S2): S235-S240. doi: https://doi.org/10.1089/dia.2019.0019

46. Bollyky JB, Bravata D, Yang J, et al. Remote lifestyle coaching plus a connected glucose meter with certified diabetes educator support improves glucose and weight loss for people with type 2 diabetes. J Diabetes Res. 2018;2018:1-7. doi: https://doi.org/10.1155/2018/3961730

47. Amante DJ, Harlan DM, Lemon SC, et al. Evaluation of a diabetes remote monitoring program facilitated by connected glucose meters for patients with poorly controlled type 2 diabetes: randomized crossover trial. JMIR Diabetes. 2021;6(1):e25574. doi: https://doi.org/10.2196/25574

48. Speyer R, Denman D, Wilkes-Gillan S, et al. Effects of telehealth by allied health professionals and nurses in rural and remote areas: A systematic review and meta-analysis. J Rehabil Med. 2018;50(3):225-235. doi: https://doi.org/10.2340/16501977-2297

49. Klimontov VV, Berikov VB, Saik OV. Artificial intelligence in diabetology. Diabetes mellitus. 2021;24(2):156-166. (In Russ.). doi: https://doi.org/10.14341/DM12665

50. Schönenberger KA, Cossu L, Prendin F, et al. Digital solutions to diagnose and manage postbariatric hypoglycemia. Front Nutr. 2022;(9). doi: https://doi.org/10.3389/fnut.2022.855223


Supplementary files

1. Figure 1. History of the Contour, Accu-Chek and OneTouch glucometers.
Subject
Type Исследовательские инструменты
View (609KB)    
Indexing metadata ▾
2. Figure 2. History of the development of Russian glucometers.
Subject
Type Исследовательские инструменты
View (470KB)    
Indexing metadata ▾

Review

For citations:


Suplotova L.A., Alieva O.O. Evolution of blood glucose self-monitoring technology. Diabetes mellitus. 2023;26(6):566-574. (In Russ.) https://doi.org/10.14341/DM13063

Views: 2970


ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)